Y-mAbs Therapeutics, Inc. (YMAB) Margin Analysis - Discounting Cash Flows
YMAB
Y-mAbs Therapeutics, Inc.
YMAB (NASDAQ)

Years and Quarters

Years

Years

The number of historical years used to render the annual chart and tables.

Quarters

Quarters

The number of historical quarters used to render the quarterly chart and tables.

Margin Analysis Report

Margins refer to the ratio between a financial report item and the revenue (example: Net Income Margin = Net Income / Revenue).

This analysis provides annual and quarterly sections for reporting key financial margins.

Annual Section

The annual section uses annual data to calculate margins and growth rates.

Monetary values in USD

amounts except #

LTM
Apr 18
2024
Dec 31
2023
Dec 31
2022
Dec 31
2021
Dec 31
Revenue 85.39 87.69 84.82 65.27 34.9
Revenue Growth Rate -2.62% 3.38% 29.96% 87.03% 68.18%
Cost of Revenue 15.75 15.25 11.42 7.57 2.51
Gross Profit 69.63 72.43 73.4 57.7 32.38
Gross Margin 81.55% 82.61% 86.54% 88.41% 92.8%
Operating Income -26.65 -31.2 -25.67 -94.81 -115.4
Operating Margin -31.21% -35.58% -30.27% -145.3% -330.8%
Net Income -22.22 -29.67 -21.43 -95.57 -55.27
Net Margin -26.03% -33.83% -25.26% -146.4% -158.4%

Monetary values in USD

amounts except #

LTM
Apr 18
2024
Dec 31
2023
Dec 31
2022
Dec 31
2021
Dec 31
Revenue 85.39 87.69 84.82 65.27 34.9
Cash from Operating Activities -17.8 -15.71 -27.23 -75.92 -102.6
Cash from Operating Activities Margin -20.84% -17.92% -32.11% -116.3% -293.9%
Free Cash Flow -17.92 -15.71 -27.23 -75.92 -103.5
Free Cash Flow Margin -20.99% -17.92% -32.11% -116.3% -296.7%
Depreciation and Amortization 0.347 0.535 0.735 0.839 0.782
Depreciation and Amortization Margin 0.406% 0.61% 0.867% 1.29% 2.24%
Capital Expenditure -0.127 0 0 0 -0.967
Capital Expenditure Margin -0.149% 0% 0% 0% -2.77%

Annual Chart

Monetary values in USD

Quarterly Section

The quarterly section uses quarterly data to calculate margins and growth rates.

Monetary values in USD

amounts except #

2025 (Q2)
Jun 30
2025 (Q1)
Mar 31
2024 (Q4)
Dec 31
2024 (Q3)
Sep 30
2024 (Q2)
Jun 30
2024 (Q1)
Mar 31
2023 (Q4)
Dec 31
2023 (Q3)
Sep 30
2023 (Q2)
Jun 30
Revenue 19.52 20.9 26.5 18.46 22.8 19.93
Revenue Growth Rate -6.6% -21.1% 43.52% -19.02% 14.38%
Cost of Revenue 2.66 3 7.84 2.25 3.01 2.15
Gross Profit 16.86 17.9 18.65 16.21 19.78 17.78
Gross Margin 86.37% 85.64% 70.4% 87.82% 86.78% 89.23%
Operating Income -5.6 -6.54 -5.94 -8.57 -9.79 -6.91
Operating Margin -28.7% -31.3% -22.4% -46.41% -42.94% -34.66%
Net Income -3.24 -5.2 -6.79 -7 -9.25 -6.63
Net Margin -16.59% -24.86% -25.63% -37.91% -40.57% -33.26%

Monetary values in USD

amounts except #

2025 (Q2)
Jun 30
2025 (Q1)
Mar 31
2024 (Q4)
Dec 31
2024 (Q3)
Sep 30
2024 (Q2)
Jun 30
2024 (Q1)
Mar 31
2023 (Q4)
Dec 31
2023 (Q3)
Sep 30
2023 (Q2)
Jun 30
Revenue 19.52 20.9 26.5 18.46 22.8 19.93
Cash from Operating Activities 1.65 -6.91 -1.87 -10.66 0.298 -3.48
Cash from Operating Activities Margin 8.46% -33.06% -7.06% -57.77% 1.31% -17.45%
Free Cash Flow 1.65 -7.04 -1.87 -10.66 0.298 -3.48
Free Cash Flow Margin 8.46% -33.67% -7.06% -57.77% 1.31% -17.45%
Depreciation and Amortization 0.053 0.071 0.102 0.121 0.153 0.159
Depreciation and Amortization Margin 0.271% 0.34% 0.385% 0.655% 0.671% 0.798%
Capital Expenditure 0 -0.127 0 0 0 0
Capital Expenditure Margin 0% -0.608% 0% 0% 0% 0%

Quarterly Chart

Monetary values in USD

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program